Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (NYSE American: AMS) regularly issues news updates that describe its role as a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services. Its press releases highlight developments across its medical equipment leasing and direct patient care services segments, giving investors and observers insight into how the company’s cancer treatment–focused operations are evolving.
News items frequently cover quarterly and annual financial results, where the company reports revenue from Gamma Knife, linear accelerator (LINAC), and proton beam radiation therapy, as well as performance in its direct patient care services segment. These releases often include management commentary on treatment volumes, contract activity, new center openings, and the balance between leasing and direct patient care services.
American Shared Hospital Services’ news flow also emphasizes business expansion and partnerships. Recent disclosures reference acquiring majority interests in radiation therapy treatment centers in Rhode Island, opening a radiation therapy center in Puebla, Mexico, and planning additional radiation therapy and proton beam centers under Certificate of Need approvals. The company’s descriptions of turnkey solutions for cancer treatment centers, health systems, and cancer networks in North and South America are a recurring theme in its announcements.
Regulatory and corporate governance updates appear in the form of conference call announcements, shareholder meeting notices, and SEC-related disclosures. These include scheduling of earnings calls, participation in investor conferences, and information about annual shareholder meetings. Together, the AMS news feed on this page provides a centralized view of the company’s reported financial performance, operational changes in its cancer treatment services, and key corporate events.
American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call on March 24, 2022, at 4:00pm ET to discuss its Q4 and year-end 2021 financial results. The financial results press release will be available pre-market on the same day. AMS specializes in providing technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment. It is renowned for Gamma Knife radiosurgery systems and offers services in proton therapy and advanced imaging systems. For more details, visit ashs.com.
American Shared Hospital Services (AMS) reported preliminary Q4 2021 revenue of approximately $4.7 million, marking the highest quarterly revenue since the onset of the COVID-19 pandemic and stable compared to Q4 2020. For the full year, revenue totaled about $17.7 million, consistent with 2020 figures. The company noted improved operating income due to lower costs of revenue. Cash reserves increased to over $8 million, bolstered by a successful refinancing in Q2 2021. The final audited results will be released in late March 2022, accompanied by a quarterly conference call.
American Shared Hospital Services (AMS) announced a restructuring of its Board of Directors, reducing membership to five. Effective December 28, 2021, new directors Kathleen Miles and Vicki L. Wilson were appointed, while Sandra A. J. Lawrence resigned. Founding Chairman and CEO Ernest A. Bates, M.D., and David L. Larson, M.D. also resigned from the Board but will continue as consultants. Miles brings over 20 years of public finance experience, while Wilson has extensive financial management experience in the healthcare sector. This transition could signal a shift in governance aimed at enhancing operational efficiency and strategic direction.
American Shared Hospital Services (NYSE American: AMS) announced a strategic office relocation aimed at cost-saving. Effective December 1, 2021, the company will move to a smaller corporate office, resulting in estimated annual cash savings exceeding $115,000. The CEO, Ray Stachowiak, highlighted that the shift follows successful remote work adaptations during the COVID-19 pandemic, making the transition efficient. AMS is known for providing advanced stereotactic radiosurgery and radiation therapy technology.
American Shared Hospital Services (NYSE American: AMS) reported a 12.2% revenue decline to $4.1 million in Q3 2021, impacted by lower proton therapy volumes and COVID-19. Proton therapy revenue fell 23.4%, while Gamma Knife revenue decreased 5.9%. Despite this, the company achieved operating income of $186,000 compared to a loss last year. Net income was $33,000 vs. a loss of $209,000. AMS emphasizes its cost reductions leading to a 28.9% increase in gross margin and a strong cash position of $7.2 million, positioning for future growth.
American Shared Hospital Services (NYSE American: AMS) will hold a quarterly conference call to discuss its third quarter 2021 financial results on November 10, 2021, at 3:00 PM EST / 12:00 PM PST. The press release detailing the financial results will be available premarket on the same day. The call will provide insights into the company's performance in providing advanced radiation therapy equipment and services, such as Gamma Knife radiosurgery and proton therapy.
American Shared Hospital Services (NYSE American: AMS) announced an expansion of its sales efforts to include federal healthcare facilities in the U.S., encompassing Veterans Affairs (VA) and Department of Defense (DoD) hospitals. This initiative follows a partnership with Growth Strategies in Motion (GSM) to enhance business development services. With $8.4 million in cash and a $7 million line of credit, AMS aims for sustained profitability. The company is known for its Gamma Knife radiosurgery equipment and advanced radiation therapy solutions.
American Shared Hospital Services (AMS) reported a 12.2% increase in Q2 revenue, totaling $4.48 million. Proton therapy revenue rose 10.6%, driven by higher reimbursements, while Gamma Knife revenue grew 13% due to increased treatment volumes. Operating income improved to $352,000 from a loss of $570,000 last year. Despite a net loss of $87,000, net income excluding debt extinguishment stood at $157,000, or $0.03 per diluted share. Cash reserves reached $8.4 million, providing a solid foundation for future growth.
American Shared Hospital Services (NYSE American: AMS) will host a quarterly conference call on August 12, 2021, at 3:00 PM EST to discuss its second quarter 2021 financial results. The press release with financial details will be issued premarket on the same day. Participants can join by calling 1 (877) 317-6789 or via webcast on the company's website. American Shared Hospital Services specializes in advanced radiation therapy equipment and solutions, including Gamma Knife radiosurgery and proton therapy.
American Shared Hospital Services (AMS) reported breakeven results for Q1 2021, with revenues of $4.36 million, a 4.5% decline year-over-year. Proton therapy revenue fell by 8.7% to $1.53 million, while Gamma Knife revenue remained stable at $2.89 million. The company achieved an operating income of $90,000, a turnaround from a loss in the prior year. Net income was $29,000 compared to a net loss of $135,000 in Q1 2020. AMS improved its balance sheet, achieving positive working capital of $4.2 million and reducing debt obligations by approximately $5.9 million.